Attenuation of Upper Body Accelerations during Gait: Piloting an Innovative Assessment Tool for Parkinson’s Disease

Table 1

The mean (±SD) participant characteristics and spatial-temporal gait variables for the PD and control group.

	PD ( = 13)	Control ( = 19)	(-test)
Age (years)	69.7 ± 11.1	70.2 ± 6.7	0.90
Height (m)	1.70 ± 0.10	1.72 ± 0.10	0.99
Mass (Kg)	77.9 ± 13.3	83.2 ± 14.2	0.30
BMI	26.1 ± 3.3	28.0 ± 4.5	0.20
MDS UPDRS III	35.6 ± 12.6	NA	NA
Hoehn and Yahr stage	HY II: 11; HY III: 2	NA	NA
Gait speed (m/s^2)	1.22 ± 0.22	1.32 ± 0.15	0.14
Step time (s)	0.54 ± 0.21	0.54 ± 0.44	0.97
Step length (cm)	0.66 ± 0.12	0.71 ± 0.07	0.15
Step width (cm)	0.09 ± 0.03	0.09 ± 0.02	0.46

Significant difference at < 0.05.
BMI: body mass index.
MDS UPDRS III: Movement Disorders Society Revised Unified Parkinson’s Disease Rating Scale–Movement Subsection [25].
HY: Hoehn and Yahr stage [26].